Because of its prevalence and the availability of fusion-positive cell line model, the relevance of TMPRSS2-ERG for prostate cancer cells and the clinical manifestations of the disease has been widely studied and will be discussed in more detail in the following chapters. Here, ERG is linked to prostate carcinoma.